Organon launches two denosumab biosimilars in Canada

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. AKAM
2. COST
3. SPY
4. ZS
5. META
6. NVDA
7. ULS
8. DRI
9. CRL
10. VEON

Go back to Organon launches two denosumab biosimilars in Canada
(NYSE: OGN) Delayed: 13.73 +0.01 (0.07%)
Previous Close $13.72    52 Week High $8.00 
Open $13.74    52 Week Low $8.00 
Day High $13.74    P/E N/A 
Day Low $13.70    EPS $0.00 
Volume 528,851